Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
10.74
+0.37 (3.57%)
At close: Aug 3, 2026, 4:00 PM EDT
10.75
+0.01 (0.09%)
After-hours: Aug 3, 2026, 7:34 PM EDT
Korro Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 61.7 | 21.82 | 55.64 | 166.15 | 36.33 | 79.64 |
Short-Term Investments | 52.27 | 53.33 | 70.45 | - | 18.92 | 51.07 |
Cash & Short-Term Investments | 113.97 | 75.16 | 126.1 | 166.15 | 55.25 | 130.71 |
Cash Growth | -0.85% | -40.40% | -24.11% | 200.74% | -57.73% | -40.68% |
Accounts Receivable | - | 0.97 | 1.7 | - | - | - |
Other Current Assets | 6.19 | 6.25 | 3.74 | 6.58 | 1.84 | 4.04 |
Total Current Assets | 120.16 | 82.37 | 131.53 | 172.73 | 57.08 | 134.75 |
Net Property, Plant & Equipment | 15.62 | 16.22 | 51.55 | 42.82 | 11.89 | 36.87 |
Long-Term Investments | 43.08 | 10.03 | 36.96 | - | - | 11.72 |
Other Long-Term Assets | 4.76 | 4.88 | 6.2 | 6.12 | 4.77 | 2.02 |
Total Assets | 183.62 | 113.51 | 226.24 | 221.66 | 73.74 | 185.36 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.96 | 1.65 | 3.99 | 7.28 | 2.61 | 2.75 |
Accrued Expenses | 9.85 | 7.61 | 6.17 | 10.21 | 3.18 | 6.1 |
Current Portion of Long-Term Debt | - | - | - | - | - | 0.83 |
Current Portion of Leases | 2.8 | 2.67 | 1.28 | 1.99 | 2.92 | 1.75 |
Unearned Revenue | 0.18 | - | 3.51 | - | - | - |
Total Current Liabilities | 14.79 | 11.94 | 14.96 | 19.48 | 8.7 | 11.43 |
Long-Term Debt | - | - | - | - | - | 14.17 |
Long-Term Leases | 40.08 | 40.81 | 43.48 | 31.22 | 0.21 | 28.85 |
Other Long-Term Liabilities | 9.12 | 9.32 | 7.38 | 1.05 | - | 0.09 |
Total Long-Term Liabilities | 49.2 | 50.13 | 50.87 | 32.27 | 0.21 | 43.11 |
Total Liabilities | 63.99 | 62.07 | 65.83 | 51.75 | 8.91 | 54.53 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | - | 0.04 |
Additional Paid-in Capital | 523.09 | 435.06 | 426.72 | 352.91 | - | 310.94 |
Accumulated Other Comprehensive Income | 0.01 | 0.21 | 0.27 | - | - | -0.06 |
Retained Earnings | -403.47 | -383.85 | -266.59 | -183.01 | - | -180.09 |
Total Common Shareholders' Equity | 119.63 | 51.44 | 160.42 | 169.91 | - | 130.82 |
Minority Interest | - | - | - | - | 163.86 | - |
Shareholders' Equity | 119.63 | 51.44 | 160.42 | 169.91 | 163.86 | 130.82 |
Total Liabilities & Equity | 183.62 | 113.51 | 226.24 | 221.66 | 172.77 | 185.36 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 42.89 | 43.49 | 44.77 | 33.21 | 3.13 | 45.6 |
Net Cash (Debt) | 71.09 | 31.67 | 81.33 | 132.94 | 52.12 | 85.11 |
Net Cash Growth | 1.89% | -61.06% | -38.82% | 155.08% | -38.76% | -51.18% |
Net Cash Per Share | 7.14 | 3.37 | 9.12 | 86.93 | 80.80 | 131.94 |
Book Value | 119.63 | 51.44 | 160.42 | 169.91 | 0 | 130.82 |
Book Value Per Share | 12.02 | 5.47 | 17.98 | 111.10 | - | 202.81 |
Tangible Book Value | 119.63 | 51.44 | 160.42 | 169.91 | 0 | 130.82 |
Tangible Book Value Per Share | 12.02 | 5.47 | 17.98 | 111.10 | - | 202.81 |